VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $35,825 | -100.0% | 1,250 | -94.8% | 0.01% | -91.5% |
| Q1 2021 | $776,750,000 | -41.7% | 23,900 | -35.4% | 0.13% | -48.4% |
| Q4 2020 | $1,332,740,000 | +43.6% | 37,000 | +56.1% | 0.25% | +32.3% |
| Q3 2020 | $928,092,000 | -47.4% | 23,700 | -50.7% | 0.19% | -42.7% |
| Q2 2020 | $1,764,308,000 | +21.2% | 48,100 | -23.9% | 0.33% | -23.8% |
| Q1 2020 | $1,456,128,000 | +55224.0% | 63,200 | -29.7% | 0.43% | +4.1% |
| Q4 2019 | $2,632,000 | +103.6% | 89,900 | +85.7% | 0.42% | +199.3% |
| Q3 2019 | $1,293,000 | -69.5% | 48,400 | -70.8% | 0.14% | -74.8% |
| Q2 2019 | $4,238,000 | +249.4% | 165,800 | +206.5% | 0.55% | +299.3% |
| Q1 2019 | $1,213,000 | -33.9% | 54,100 | -32.3% | 0.14% | -22.5% |
| Q3 2017 | $1,835,000 | +0.3% | 79,900 | +15.5% | 0.18% | -12.3% |
| Q3 2016 | $1,829,000 | +11.5% | 69,200 | +16.9% | 0.20% | +24.5% |
| Q2 2016 | $1,640,000 | – | 59,200 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |